Our findings in lung adenocarcinoma cell line (Figure 5) and xenografts (Figure 6) support that USP22 could promote the phosphorylation of histone H2AX via deubiquitinating histone H2A, thus contributing to the DNA damage repair induced by cisplatin and leading to cisplatin resistance. The gene discussed is USP22; the disease is lung adenocarcinoma.